GlassScriptPhysician profile
Jibran Rana
NPI 1043638729
$9,424.16
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $281 · 2021: $1,503 · 2022: $2,215 · 2023: $1,800 · 2024: $2,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,807 · Food and Beverage: $1,893 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,806.70 |
| Food and Beverage | $1,892.61 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,627.92 | 2019-2024 | Optis |
| Edwards Lifesciences Corporation | $1,390.66 | 2021-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $843.71 | 2019-2022 | |
| Boston Scientific Corporation | $656.09 | 2021-2023 | Eluvia, Avvigo Guidance System |
| Shockwave Medical, INC | $607.72 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $356.47 | 2022 | |
| Cvrx, INC. | $354.71 | 2021-2022 | |
| Cardiovascular Systems INC. | $286.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $195.01 | 2019-2023 | Brilinta |
| Esperion Therapeutics, INC. | $164.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $124.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $119.55 | 2022 | |
| Teleflex LLC | $116.48 | 2022-2023 | Guideliner |
| Medtronic Vascular, INC. | $109.01 | 2019 | |
| Livanova USA, INC. | $96.43 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $79.02 | 2022 | |
| Merck Sharp & Dohme LLC | $72.59 | 2021 | |
| Veryan Medical Incorporated | $60.46 | 2022 | |
| Abiomed | $45.50 | 2021 | |
| Lantheus Medical Imaging, INC. | $44.92 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.83 | 2022 | |
| Terumo Medical Corporation | $23.08 | 2022 | |
| W. L. Gore & Associates, INC. | $12.62 | 2022 | |
| Angiodynamics, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jibran Rana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.